Company Filing History:
Years Active: 2024
Title: AeRyon Kim: Innovator in Cancer Treatment
Introduction
AeRyon Kim is a prominent inventor based in Foster City, CA (US). He has made significant contributions to the field of cancer treatment through his innovative work in antibody constructs. His research focuses on developing targeted therapies for solid tumors, which is a critical area in oncology.
Latest Patents
AeRyon Kim holds a patent for "Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors." This invention relates to a human agonistic CD40 multispecific antibody construct designed to treat solid tumors by specifically targeting the CD40 pathway on tumor-associated antigen-presenting cells (APCs), without causing systemic CD40 activation. He has 1 patent to his name.
Career Highlights
AeRyon Kim is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen focuses on advancing cancer treatment options and improving patient outcomes through targeted therapies.
Collaborations
AeRyon collaborates with talented colleagues, including Xin Yu and Jackson Egen, who contribute to his research efforts and help drive innovation in the field of cancer treatment.
Conclusion
AeRyon Kim's work exemplifies the importance of innovation in the fight against cancer. His contributions to antibody constructs are paving the way for more effective treatments for patients with solid tumors.